Randomized phase II trial comparing two chemotherapy combinations for non-small cell lung cancer. Mitomycin, ifosfamide, and cisplatin versus vindesine, ifosfamide, and cisplatin.

Source:http://linkedlifedata.com/resource/pubmed/id/8392287

Download in:

View as

General Info

PMID
8392287